12/11/2024
5:44 PM | KAKKIS EMIL D (Reporting)
Ultragenyx Pharmaceutical (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/11/2024
5:47 PM | Huizenga Theodore Alan (Reporting)
Ultragenyx Pharmaceutical (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/10/2024
3:12 PM | KAKKIS EMIL D (Reporting)
Ultragenyx Pharmaceutical (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
11/14/2024
5:42 AM | RTW INVESTMENTS, LP (Filed by)
Ultragenyx Pharmaceutical (Subject)
| Form SC 13G/A | |
11/05/2024
3:06 PM | Ultragenyx Pharmaceutical (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/11/2024
3:48 PM | Horn Howard (Reporting)
Ultragenyx Pharmaceutical (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/07/2024
7:15 AM | Ultragenyx Pharmaceutical (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
|
10/03/2024
3:34 PM | Ultragenyx Pharmaceutical (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/18/2024
12:03 PM | Huizenga Theodore Alan (Reporting)
Ultragenyx Pharmaceutical (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/05/2024
10:50 AM | Huizenga Theodore Alan (Reporting)
Ultragenyx Pharmaceutical (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/05/2024
10:53 AM | KAKKIS EMIL D (Reporting)
Ultragenyx Pharmaceutical (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/03/2024
3:40 PM | KAKKIS EMIL D (Reporting)
Ultragenyx Pharmaceutical (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/07/2024
1:48 PM | KAKKIS EMIL D (Reporting)
Ultragenyx Pharmaceutical (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/06/2024
3:28 PM | KAKKIS EMIL D (Reporting)
Ultragenyx Pharmaceutical (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
07/03/2024
1:07 PM | Sanders Corazon D. (0001796536) (Reporting)
Ultragenyx Pharmaceutical (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/20/2024
1:22 PM | Sanders Corazon D. (0001796536) (Reporting)
Ultragenyx Pharmaceutical (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/20/2024
1:23 PM | Ray Amrit (Reporting)
Ultragenyx Pharmaceutical (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/20/2024
1:24 PM | NARACHI MICHAEL (Reporting)
Ultragenyx Pharmaceutical (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/20/2024
1:25 PM | Ultragenyx Pharmaceutical (Issuer)
WELCH DANIEL G (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/20/2024
1:26 PM | Fust Matthew K (Reporting)
Ultragenyx Pharmaceutical (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/20/2024
1:29 PM | Dunsire Deborah (Reporting)
Ultragenyx Pharmaceutical (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/20/2024
1:22 PM | SULIMAN SHEHNAAZ (Reporting)
Ultragenyx Pharmaceutical (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/17/2024
5:31 AM | Ultragenyx Pharmaceutical (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/14/2024
4:11 PM | Ultragenyx Pharmaceutical (Filer)
| Form 424B5 | |
06/12/2024
6:47 PM | Parschauer Karah Herdman (Reporting)
Ultragenyx Pharmaceutical (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/12/2024
4:10 PM | Parschauer Karah Herdman (Reporting)
Ultragenyx Pharmaceutical (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/12/2024
4:20 PM | Ultragenyx Pharmaceutical (Filer)
| Form 424B5 | |
06/10/2024
6:58 PM | Sanders Corazon D. (0001796536) (Reporting)
Ultragenyx Pharmaceutical (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/10/2024
4:20 PM | Sanders Corazon D. (0001796536) (Reporting)
Ultragenyx Pharmaceutical (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
05/03/2024
2:23 PM | Crombez Eric (Reporting)
Ultragenyx Pharmaceutical (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/19/2024
3:35 PM | Crombez Eric (Reporting)
Ultragenyx Pharmaceutical (Issuer)
Ultragenyx Pharmaceutical (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/18/2024
5:06 PM | Huizenga Theodore Alan (Reporting)
Ultragenyx Pharmaceutical (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/15/2024
7:07 AM | Ultragenyx Pharmaceutical (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/12/2024
12:41 PM | Kassberg Thomas Richard (Reporting)
Ultragenyx Pharmaceutical (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/11/2024
5:39 PM | Kassberg Thomas Richard (Reporting)
Ultragenyx Pharmaceutical (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/11/2024
11:54 AM | Fust Matthew K (Reporting)
Ultragenyx Pharmaceutical (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/05/2024
7:13 PM | Huizenga Theodore Alan (Reporting)
Ultragenyx Pharmaceutical (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/05/2024
7:15 PM | Pinion John Richard (Reporting)
Ultragenyx Pharmaceutical (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/05/2024
7:17 PM | Huang Dennis Karl (Reporting)
Ultragenyx Pharmaceutical (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/05/2024
7:19 PM | Kassberg Thomas Richard (Reporting)
Ultragenyx Pharmaceutical (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/05/2024
7:22 PM | Parschauer Karah Herdman (Reporting)
Ultragenyx Pharmaceutical (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
Nvidia’s Bold Move: Tackling Tech’s $1 Trillion Crisis (Ad) Taiwan Semiconductor, a partner of Nvidia’s for more than two decades, has seen its shares explode as much as 4,744%.
Now, if you’re like everybody else, you want to know what Nvidia’s doing next … and who they’re going to partner with … Find out details on these three critical Nvidia partners immediately. |
03/05/2024
7:23 PM | Horn Howard (Reporting)
Ultragenyx Pharmaceutical (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/05/2024
7:06 PM | KAKKIS EMIL D (Reporting)
Ultragenyx Pharmaceutical (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/05/2024
7:08 PM | Harris Erik (Reporting)
Ultragenyx Pharmaceutical (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/05/2024
7:10 PM | Crombez Eric (Reporting)
Ultragenyx Pharmaceutical (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/14/2024
6:46 AM | RTW INVESTMENTS, LP (Filed by)
Ultragenyx Pharmaceutical (Subject)
| Form SC 13G/A | |
02/13/2024
2:41 PM | SANDS CAPITAL MANAGEMENT, LLC (Filed by)
Ultragenyx Pharmaceutical (Subject)
| Form SC 13G | |
02/08/2024
2:49 PM | KAKKIS EMIL D (Reporting)
Ultragenyx Pharmaceutical (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/08/2024
9:18 AM | Ultragenyx Pharmaceutical (Subject)
WELLINGTON MANAGEMENT GROUP LLP (Filed by)
| Form SC 13G/A | |
01/29/2024
2:26 PM | BlackRock Inc. (Filed by)
Ultragenyx Pharmaceutical (Subject)
| Form SC 13G/A | |
01/08/2024
5:03 AM | Ultragenyx Pharmaceutical (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
